Helen Künstlinger

838 total citations
11 papers, 279 citations indexed

About

Helen Künstlinger is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Helen Künstlinger has authored 11 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Gastroenterology and 3 papers in Surgery. Recurrent topics in Helen Künstlinger's work include Gastrointestinal Tumor Research and Treatment (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Gastric Cancer Management and Outcomes (3 papers). Helen Künstlinger is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Gastric Cancer Management and Outcomes (3 papers). Helen Künstlinger collaborates with scholars based in Germany. Helen Künstlinger's co-authors include Sabine Merkelbach‐Bruse, Hans‐Ulrich Schildhaus, Eva Wardelmann, Elke Binot, Sebastian Huss, Reinhard Büttner, Wolfgang Hartmann, Jens Mittler, Jana Fassunke and Reinhard Buettner and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Helen Künstlinger

10 papers receiving 277 citations

Peers

Helen Künstlinger
Hosub Park South Korea
Inge Losen Germany
Dennis Lim Singapore
Kayuri Patel United States
Mohanpal Dulai United States
Helen Künstlinger
Citations per year, relative to Helen Künstlinger Helen Künstlinger (= 1×) peers Vanessa Vanspauwen

Countries citing papers authored by Helen Künstlinger

Since Specialization
Citations

This map shows the geographic impact of Helen Künstlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Künstlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Künstlinger more than expected).

Fields of papers citing papers by Helen Künstlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Künstlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Künstlinger. The network helps show where Helen Künstlinger may publish in the future.

Co-authorship network of co-authors of Helen Künstlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Künstlinger. A scholar is included among the top collaborators of Helen Künstlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Künstlinger. Helen Künstlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Künstlinger, Helen, Uta Drebber, Sabine Merkelbach‐Bruse, et al.. (2016). MDM2 gene amplification in esophageal carcinoma. Oncology Reports. 35(4). 2223–2227. 17 indexed citations
2.
Heydt, Carina, Jana Fassunke, Helen Künstlinger, et al.. (2015). Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy. BMC Cancer. 15(1). 291–291. 6 indexed citations
3.
Schmitz, Katja, Hartmut Koeppen, Elke Binot, et al.. (2015). MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas. PLoS ONE. 10(4). e0120079–e0120079. 15 indexed citations
4.
Künstlinger, Helen, Jana Fassunke, Hans‐Ulrich Schildhaus, et al.. (2015). FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro. Oncotarget. 6(24). 20215–20230. 23 indexed citations
5.
Heydt, Carina, Jana Fassunke, Helen Künstlinger, et al.. (2014). Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics. PLoS ONE. 9(8). e104566–e104566. 40 indexed citations
6.
Huss, Sebastian, Helen Künstlinger, Eva Wardelmann, et al.. (2013). A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del). Modern Pathology. 26(7). 1004–1012. 44 indexed citations
7.
Künstlinger, Helen, Elke Binot, Sabine Merkelbach‐Bruse, et al.. (2013). High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors. Human Pathology. 45(3). 573–582. 14 indexed citations
8.
Künstlinger, Helen, Sebastian Huss, Sabine Merkelbach‐Bruse, et al.. (2013). Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations. The American Journal of Surgical Pathology. 37(11). 1648–1659. 31 indexed citations
9.
Huss, Sebastian, Elke Binot, Eva Wardelmann, et al.. (2012). β‐Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid‐type fibromatosis. Histopathology. 62(2). 294–304. 80 indexed citations
10.
Merkelbach‐Bruse, Sabine, Eva Wardelmann, Helen Künstlinger, Reinhard Büttner, & Hans‐Ulrich Schildhaus. (2010). Molekulare Methoden in der Sarkomdiagnostik. Der Pathologe. 32(1). 24–31.
11.
Fassunke, Jana, Hans‐Ulrich Schildhaus, Marc Zapatka, et al.. (2010). qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL. BMC Molecular Biology. 11(1). 100–100. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026